Dr. Christopher Saigal

Dr. Christopher Saigal
Christopher Saigal MD, MPH is Professor and Vice Chair of Urology at the UCLA School of Medicine and a PI at RAND Corporation. Dr Saigal’s major research area is in shared decision making, where he has been funded by an R-01 from the National Cancer Institute to innovate new approaches to shared decision making in men with prostate cancer. As a former Gallagher Health Policy Scholar and American Urological Association Quality Improvement and Patient Safety committee member, he has provided leadership on behalf of the AUA in many arenas, including the Surgical Quality Alliance. He has chaired or served as a committee member for several National Quality Forum (NQF) surgical quality measurement efforts. He also co-chaired the NQF decision aids certification panel, and is a leader in the NQF Shared Decision Making action team. His surgical practice in urologic oncology is at the Ronald Reagan Medical Center in Westwood.
Medical School:

UCLA

Residency:

UCLA

Fellowship:

UCLA

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only